IL233351A - Use of apolipoprotein a – iv without glycosylation for the preparation of diabetes medications - Google Patents

Use of apolipoprotein a – iv without glycosylation for the preparation of diabetes medications

Info

Publication number
IL233351A
IL233351A IL233351A IL23335114A IL233351A IL 233351 A IL233351 A IL 233351A IL 233351 A IL233351 A IL 233351A IL 23335114 A IL23335114 A IL 23335114A IL 233351 A IL233351 A IL 233351A
Authority
IL
Israel
Prior art keywords
medicaments
diabetes
preparation
treatment
glycosylated apolipoprotein
Prior art date
Application number
IL233351A
Other languages
English (en)
Hebrew (he)
Other versions
IL233351A0 (en
Original Assignee
University Of Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/021802 external-priority patent/WO2012100010A1/en
Application filed by University Of Cincinnati filed Critical University Of Cincinnati
Publication of IL233351A0 publication Critical patent/IL233351A0/en
Publication of IL233351A publication Critical patent/IL233351A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL233351A 2012-01-19 2014-06-24 Use of apolipoprotein a – iv without glycosylation for the preparation of diabetes medications IL233351A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2012/021802 WO2012100010A1 (en) 2011-01-19 2012-01-19 Apolipoprotein aiv as an antidiabetic peptide
US201261675692P 2012-07-25 2012-07-25
PCT/US2012/066314 WO2013109342A1 (en) 2012-01-19 2012-11-21 Method of treating diabetes using non-glycosylated apolipoprotein a-iv

Publications (2)

Publication Number Publication Date
IL233351A0 IL233351A0 (en) 2014-08-31
IL233351A true IL233351A (en) 2016-12-29

Family

ID=48799573

Family Applications (1)

Application Number Title Priority Date Filing Date
IL233351A IL233351A (en) 2012-01-19 2014-06-24 Use of apolipoprotein a – iv without glycosylation for the preparation of diabetes medications

Country Status (13)

Country Link
US (1) US9951120B2 (enExample)
EP (1) EP2804618B1 (enExample)
JP (1) JP6310398B2 (enExample)
KR (1) KR20140117565A (enExample)
CN (1) CN104066436B (enExample)
AU (1) AU2012366182B2 (enExample)
BR (1) BR112014017141A2 (enExample)
CA (1) CA2860782A1 (enExample)
EA (1) EA028230B1 (enExample)
HK (1) HK1203823A1 (enExample)
IL (1) IL233351A (enExample)
MX (1) MX357071B (enExample)
WO (1) WO2013109342A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012100010A1 (en) 2011-01-19 2012-07-26 University Of Cincinnati Apolipoprotein aiv as an antidiabetic peptide
MX357071B (es) 2012-01-19 2018-06-22 Univ Cincinnati Medicamentos que comprenden apolipoproteína a-iv no glicosilada para el tratamiento de diabetes.
JP2015524808A (ja) 2012-07-25 2015-08-27 ユニバーシティ・オブ・シンシナティ アポリポタンパク質ａｉｖを用いたｉ型糖尿病の治療法
US10232019B2 (en) 2012-07-25 2019-03-19 University Of Cincinnati Method of treating hyperglycemic disorders using apolipoprotein AIV
US10138469B2 (en) * 2014-06-23 2018-11-27 Toagosei Co., Ltd. Synthetic peptide and use thereof
CN112546201A (zh) * 2019-09-26 2021-03-26 中国科学院生物物理研究所 人工脂蛋白颗粒apoA-Ⅳ脂肪体在治疗和/或预防糖尿病中的应用
CN113018459A (zh) * 2021-03-09 2021-06-25 百码科技(深圳)有限公司 一种基因治疗减肥的生物药剂及其制备方法
CN112891561A (zh) * 2021-03-09 2021-06-04 百码科技(深圳)有限公司 一种基因治疗脂肪肝的生物药剂及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
FR2686605B1 (fr) * 1992-01-27 1994-03-11 Rhone Poulenc Rorer Sa Nouveaux polypeptides, leur preparation et leur utilisation.
AU7242394A (en) 1993-05-28 1994-12-20 Merck & Co., Inc. Method to control appetite and treat obesity
US6729075B2 (en) * 2000-10-19 2004-05-04 Wenger Corporation Audience seating system
CN1668645A (zh) 2002-05-17 2005-09-14 埃斯佩里安医疗公司 治疗缺血再灌注的方法和组合物
JP2009542813A (ja) * 2006-07-11 2009-12-03 ハルクネスス プハルマセウティカルス，インコーポレイテッド 飽食因子を使用して肥満を治療する方法
US20100267052A1 (en) 2006-09-01 2010-10-21 American Type Culture Collection Compositions and methods for diagnosis and treatment of type 2 diabetes
AU2009226246A1 (en) * 2008-03-21 2009-09-24 Podiceps B.V. Diagnostic of pre-symptomatic metabolic syndrome
CN103788043B (zh) 2008-11-28 2016-02-03 中国医学科学院药物研究所 硝克柳胺化合物晶iv型、其制法和其药物组合物与用途
RU2631001C2 (ru) * 2010-08-30 2017-09-15 Ф.Хоффманн-Ля Рош Аг Способ получения полипептида
WO2012100010A1 (en) 2011-01-19 2012-07-26 University Of Cincinnati Apolipoprotein aiv as an antidiabetic peptide
MX357071B (es) 2012-01-19 2018-06-22 Univ Cincinnati Medicamentos que comprenden apolipoproteína a-iv no glicosilada para el tratamiento de diabetes.
US10232019B2 (en) * 2012-07-25 2019-03-19 University Of Cincinnati Method of treating hyperglycemic disorders using apolipoprotein AIV
JP2015524808A (ja) 2012-07-25 2015-08-27 ユニバーシティ・オブ・シンシナティ アポリポタンパク質ａｉｖを用いたｉ型糖尿病の治療法

Also Published As

Publication number Publication date
KR20140117565A (ko) 2014-10-07
AU2012366182B2 (en) 2017-08-17
HK1203823A1 (en) 2015-11-06
IL233351A0 (en) 2014-08-31
EA201491369A1 (ru) 2015-03-31
JP6310398B2 (ja) 2018-04-11
BR112014017141A2 (pt) 2019-09-24
CN104066436A (zh) 2014-09-24
WO2013109342A8 (en) 2014-09-04
CN104066436B (zh) 2016-12-14
US20150011469A1 (en) 2015-01-08
CA2860782A1 (en) 2013-07-25
JP2015506942A (ja) 2015-03-05
EA028230B1 (ru) 2017-10-31
MX357071B (es) 2018-06-22
EP2804618A1 (en) 2014-11-26
AU2012366182A1 (en) 2014-08-07
AU2012366182A8 (en) 2015-06-18
MX2014008829A (es) 2014-10-24
WO2013109342A1 (en) 2013-07-25
EP2804618B1 (en) 2018-03-07
US9951120B2 (en) 2018-04-24

Similar Documents

Publication Publication Date Title
IL253225A0 (en) Sulfamoyl-arylamides and their use as drugs to treat jaundice b
ZA201403795B (en) Formulations for the treatment of diabetes
IL237275A0 (en) Compounds for the treatment of paramoxovirus viral infections
IL222890A0 (en) Medicaments for the treatment of il-1beta related conditions
ZA201501977B (en) Orally administered medical composition
SG11201401907TA (en) Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
ZA201500229B (en) Combinations of modalities for the treatment of diabetes
AP2015008366A0 (en) 2-Phenyl-5-heterocyclyl-tetrahydro-2H-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders
EP2867239A4 (en) OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DIABETES
AP2013007179A0 (en) Glycoside derivatives and their uses for the treatment of diabetes
IL232384A (en) Use of lupanate compounds or lupanic acid for the preparation of anti-gout drugs
IL233351A0 (en) A method for the treatment of diabetes using apolipoprotein a-iv without glycosylation
IL234796B (en) Compounds for the treatment of diseases related to ischemia-reperfusion
ZA201400488B (en) Compounds for the treatment of cancers associated with human papillomavirus
HUP1200552A2 (en) Pharmaceutical compositions for the treatment of high blood pressure
IL232294A0 (en) Preparations for the treatment of diabetes
GB201207476D0 (en) pharmaceutical for the treatment of leishmaniasis
HUP1100245A2 (en) Pharmaceutical composition for the treatment of wounds
HK1193342A (en) Pharmaceutical combination for use in the treatment of diabetes type 2
AP2015008270A0 (en) Preparation for the treatment of tuberculosis
SI2812351T1 (sl) Farmacevtski sestavek za zdravljenje multiple skleroze

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed